Annals of Neurology:帕金森患深部脑刺激者,葡萄糖代谢障碍,是否影响认知功能

2022-02-14 Freeman MedSci原创

GBA突变和STN-DBS的综合效应对认知有负面影响。

帕金森病(PD)在美国至少影响了100万人,1每年约有9000名PD患者选择将深部脑刺激器(DBS)植入丘脑下核(STN)。

携带葡萄糖脑苷脂酶(GBA)基因(PD-GBA)突变的PD患者尤其值得关注,因为他们的认知障碍风险增加。PD-GBA受试者的葡萄糖脑苷脂酶(GCase)活性降低,导致鞘磷脂代谢紊乱,与非突变携带者相比,路易体病变的积累和扩散更快。

PD-GBA与疾病的早期发病有关,因此这些人可能更倾向于追求DBS。接受DBS的PD受试者中高达17%携带GBA变体。这比一般PD人群的频率要高,因为选择DBS的人往往更年轻,有明确的左旋多巴反应,并且有麻烦的临床特征,符合DBS的要求,如运动障碍和运动波动。 重要的是,STN-DBS本身会损害认知能力,对语言流畅性、行动的执行控制和抑制性控制有负面影响。


鉴于STN的解剖结构紧凑,有可能出现意外的电流扩散到邻近的联想和边缘亚区、邻近的纤维束或其他邻近的核团,如黑质。 此外,最近的一项试点研究发现,PDGBA与非GBA受试者的β功率存在差异,表明基因型可能与特定的神经生理学变化有关。这些生理学变化是否是DBS异质性结果的原因,还有待探讨。

藉此,Rutgers-Robert Wood Johnson Medical School的Gian Pal等人,探究了GBA和STN-DBS对全局认知的综合影响。他们探究了4组患者的认知的纵向变化。并研究了4组患者认知的纵向变化:有无DBS的GBA携带者(GBA+DBS+,GBA+DBS-),有无DBS的非携带者(GBA-DBS+,GBA-DBS-)。他们假设,与其他组相比,GBA+DBS+对象的认知下降速度最快。

他们利用了12个数据集的临床和遗传数据。使用Mattis痴呆评分表(MDRS)评估全球认知能力。对受试者进行GBA突变检查,并将其分为有或无DBS的GBA携带者(GBA+DBS+,GBA+DBS-),以及有或无DBS的非携带者(GBA-DBS+,GBA-DBS-)。GBA突变携带者根据突变严重程度(风险变异、轻度、重度)进行了分类。根据GBA和DBS状态,然后根据GBA严重程度和DBS状态,用线性混合模型比较各组中MDRS评分随时间的变化率。

366名受试者(58名GBA+DBS+,82名GBA+DBS-,98名GBA-DBS+,128名GBA-DBS-受试者)的数据是可用的,他们被纵向追踪(范围=术后36-60个月)。使用MDRS,GBA+DBS+受试者比GBA-DBS-受试者平均下降2.02分/年(95%置信区间[CI]=-2.35至-1.69),比GBA+DBS-受试者多1.71分/年(95%CI=-2.14至-1.28),比GBA-DBS+受试者多1.49分/年(95%CI=-1.80至1.18)。

该研究的重要意义在于发现了:GBA突变和STN-DBS的综合效应对认知有负面影响。对待进行DBS进行GBA突变筛查,作为手术前决策过程的一部分。


原文出处:
Pal G, Mangone G, Hill EJ, et al. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in  GBA Mutation Carriers. Annals of Neurology. Published online January 25, 2022:ana.26302. doi:10.1002/ana.26302

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2001728, encodeId=82bd2001e2858, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 12 06:15:27 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193359, encodeId=d1671193359e3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4596497456, createdName=ms8000001254116740, createdTime=Mon Feb 14 17:16:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193356, encodeId=d905119335666, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Mon Feb 14 16:55:38 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193329, encodeId=896d1193329e9, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c26469859, createdName=ms1000000262744182, createdTime=Mon Feb 14 16:18:00 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360631, encodeId=5d3f136063107, content=<a href='/topic/show?id=16a6e66155b' target=_blank style='color:#2F92EE;'>#糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76615, encryptionId=16a6e66155b, topicName=糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457684, encodeId=b0a1145e68499, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553661, encodeId=f923155366123, content=<a href='/topic/show?id=abae8824611' target=_blank style='color:#2F92EE;'>#葡萄糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88246, encryptionId=abae8824611, topicName=葡萄糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e414392307, createdName=wfang550, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-08-12 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2001728, encodeId=82bd2001e2858, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 12 06:15:27 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193359, encodeId=d1671193359e3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4596497456, createdName=ms8000001254116740, createdTime=Mon Feb 14 17:16:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193356, encodeId=d905119335666, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Mon Feb 14 16:55:38 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193329, encodeId=896d1193329e9, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c26469859, createdName=ms1000000262744182, createdTime=Mon Feb 14 16:18:00 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360631, encodeId=5d3f136063107, content=<a href='/topic/show?id=16a6e66155b' target=_blank style='color:#2F92EE;'>#糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76615, encryptionId=16a6e66155b, topicName=糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457684, encodeId=b0a1145e68499, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553661, encodeId=f923155366123, content=<a href='/topic/show?id=abae8824611' target=_blank style='color:#2F92EE;'>#葡萄糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88246, encryptionId=abae8824611, topicName=葡萄糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e414392307, createdName=wfang550, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-14 ms8000001254116740

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2001728, encodeId=82bd2001e2858, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 12 06:15:27 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193359, encodeId=d1671193359e3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4596497456, createdName=ms8000001254116740, createdTime=Mon Feb 14 17:16:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193356, encodeId=d905119335666, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Mon Feb 14 16:55:38 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193329, encodeId=896d1193329e9, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c26469859, createdName=ms1000000262744182, createdTime=Mon Feb 14 16:18:00 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360631, encodeId=5d3f136063107, content=<a href='/topic/show?id=16a6e66155b' target=_blank style='color:#2F92EE;'>#糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76615, encryptionId=16a6e66155b, topicName=糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457684, encodeId=b0a1145e68499, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553661, encodeId=f923155366123, content=<a href='/topic/show?id=abae8824611' target=_blank style='color:#2F92EE;'>#葡萄糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88246, encryptionId=abae8824611, topicName=葡萄糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e414392307, createdName=wfang550, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-14 ms2000001939126778

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2001728, encodeId=82bd2001e2858, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 12 06:15:27 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193359, encodeId=d1671193359e3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4596497456, createdName=ms8000001254116740, createdTime=Mon Feb 14 17:16:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193356, encodeId=d905119335666, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Mon Feb 14 16:55:38 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193329, encodeId=896d1193329e9, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c26469859, createdName=ms1000000262744182, createdTime=Mon Feb 14 16:18:00 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360631, encodeId=5d3f136063107, content=<a href='/topic/show?id=16a6e66155b' target=_blank style='color:#2F92EE;'>#糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76615, encryptionId=16a6e66155b, topicName=糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457684, encodeId=b0a1145e68499, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553661, encodeId=f923155366123, content=<a href='/topic/show?id=abae8824611' target=_blank style='color:#2F92EE;'>#葡萄糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88246, encryptionId=abae8824611, topicName=葡萄糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e414392307, createdName=wfang550, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-14 ms1000000262744182

    11

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2001728, encodeId=82bd2001e2858, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 12 06:15:27 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193359, encodeId=d1671193359e3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4596497456, createdName=ms8000001254116740, createdTime=Mon Feb 14 17:16:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193356, encodeId=d905119335666, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Mon Feb 14 16:55:38 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193329, encodeId=896d1193329e9, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c26469859, createdName=ms1000000262744182, createdTime=Mon Feb 14 16:18:00 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360631, encodeId=5d3f136063107, content=<a href='/topic/show?id=16a6e66155b' target=_blank style='color:#2F92EE;'>#糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76615, encryptionId=16a6e66155b, topicName=糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457684, encodeId=b0a1145e68499, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553661, encodeId=f923155366123, content=<a href='/topic/show?id=abae8824611' target=_blank style='color:#2F92EE;'>#葡萄糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88246, encryptionId=abae8824611, topicName=葡萄糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e414392307, createdName=wfang550, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-14 zz70
  6. [GetPortalCommentsPageByObjectIdResponse(id=2001728, encodeId=82bd2001e2858, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 12 06:15:27 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193359, encodeId=d1671193359e3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4596497456, createdName=ms8000001254116740, createdTime=Mon Feb 14 17:16:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193356, encodeId=d905119335666, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Mon Feb 14 16:55:38 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193329, encodeId=896d1193329e9, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c26469859, createdName=ms1000000262744182, createdTime=Mon Feb 14 16:18:00 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360631, encodeId=5d3f136063107, content=<a href='/topic/show?id=16a6e66155b' target=_blank style='color:#2F92EE;'>#糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76615, encryptionId=16a6e66155b, topicName=糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457684, encodeId=b0a1145e68499, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553661, encodeId=f923155366123, content=<a href='/topic/show?id=abae8824611' target=_blank style='color:#2F92EE;'>#葡萄糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88246, encryptionId=abae8824611, topicName=葡萄糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e414392307, createdName=wfang550, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-14 amyloid
  7. [GetPortalCommentsPageByObjectIdResponse(id=2001728, encodeId=82bd2001e2858, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 12 06:15:27 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193359, encodeId=d1671193359e3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4596497456, createdName=ms8000001254116740, createdTime=Mon Feb 14 17:16:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193356, encodeId=d905119335666, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Mon Feb 14 16:55:38 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193329, encodeId=896d1193329e9, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c26469859, createdName=ms1000000262744182, createdTime=Mon Feb 14 16:18:00 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360631, encodeId=5d3f136063107, content=<a href='/topic/show?id=16a6e66155b' target=_blank style='color:#2F92EE;'>#糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76615, encryptionId=16a6e66155b, topicName=糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457684, encodeId=b0a1145e68499, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553661, encodeId=f923155366123, content=<a href='/topic/show?id=abae8824611' target=_blank style='color:#2F92EE;'>#葡萄糖代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88246, encryptionId=abae8824611, topicName=葡萄糖代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e414392307, createdName=wfang550, createdTime=Mon Feb 14 14:15:27 CST 2022, time=2022-02-14, status=1, ipAttribution=)]

相关资讯

Annals of Neurology:帕金森步态障碍,皮层活动可参与补偿性步态改善

补偿策略的应用导致皮层活动与无提示步态相比发生变化,这不能完全归因于提示方式的感觉处理

Neurology:前瞻性队列研究: 多多摄入类黄酮,或改善帕金森病患者死亡率!

近日,研究人员前瞻性地研究诊断前后类黄酮摄入量与PD患者死亡风险之间的关系。在PD患者中,黄酮类化合物的摄入量较高,尤其是花青素和黄酮 -3- 醇,以及富含黄酮类化合物的食物,或与PD死亡率更低有关。

Neurology:神经节后超声检测的形态功能对比,有助于早期鉴别多系统萎缩(MSA-P)和帕金森病(PD)!

  近日,有研究人员定量评估了动态汗液试验和皮肤自主神经,这一方法提供了一个敏感的形态功能方法以评估神经节后泌汗神经通路的组成部分:相较于PD,上述部分在疾病过程早期更多参与MSA-P。

Neurology:坚持高水平体育锻炼与早期帕金森病临床进程密切相关!

近日,有研究人员试图探讨有规律的身体活动和锻炼习惯对帕金森病的长期影响。从长远来看,保持较高的有规律的体育活动水平和运动习惯与帕金森病的临床进程密切相关,不同类型的体育活动具有不同的效果。

JPD:环境和遗传 因素,相互作用可影响帕金森病

PD与环境因素之间的关系可以得到证实。

Annals of Neurology:帕金森,经常有氧锻炼可改善认知功能

有氧运动能稳定皮质脑区感觉运动网络的疾病进展,并能提高认知能力。

拓展阅读

暨南大学张雪娟/黄莹《AFM》:基于嗅区沉积调控和抗氧化策略的溶性液晶鼻喷雾剂用于改善帕金森病的治疗

本研究构建了一种以溶致液晶(LLC)为基材的搭载帕金森病一线治疗药物LDA和抗氧化药物表没食子儿茶素没食子酸酯(EGCG)的原位凝胶鼻喷剂LDA-EGCG IN。

脑病肠治,再添实锤!| 最新研究发现:靶向脑肠轴,为帕金森病干预策略提供新思路

本文介绍帕金森病等突触核蛋白病,强调脑肠轴机制,如肠道菌群失调可致帕金森样行为。甘露特钠靶向脑肠轴可改善相关症状,基于脑肠轴的整体治疗观或用于更多神经系统疾病。

帕金森病康复训练新方法 | 虚拟现实(VR)

帕金森病(PD)是第二大常见的神经退行性疾病,损害平衡和运动功能,其最主要的病理改变是中脑黑质多巴胺能神经元的变性死亡,由此而引起纹状体DA含量显著性减少而致病。

帕金森病屡获新突破,美国仍有192项在研基金支持(2024)

我们仅对美国国立卫生研究院(NIH)资助的在研帕金森相关项目进行梳理,希望给同仁们的选题思路提供一点启发。

王共强:关注帕金森病的情感淡漠 | AHNA&2024

情感淡漠(apathy)是指一种动机减少的行为状态,临床表现为目标导向行为的减少和不同程度兴趣和情感的降低,并且不是因为意识水平下降引起。

The Lancet:帕金森病的未来是什么?

《The Lancet》发表帕金森病系列文章,探讨其流行病学、病因及治疗,强调患病率上升及未满足需求,需多管齐下预防及更好治疗,为改善患者生活质量,疾病缓解治疗是目标。

2024 NICE 诊断指南:帕金森病远程监测设备 [DG51]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-01-25